About This Event
CG Oncology (Nasdaq: CGON), a late-stage clinical biopharmaceutical company, visits the Nasdaq MarketSite in Times Square. The company is focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.
In honor of the occasion, Arthur Kuan, CEO and Chairman, rings the Opening Bell.